ASLAN Pharmaceuticals Limited (ASLN)
Company Info
| ISIN | US04522R1014 |
|---|---|
| CUSIP | 04522R101 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $11.97M |
|---|---|
| EPS | -$2.96 |
| Revenue (TTM) | $12.00M |
| Gross Profit (TTM) | $79.82M |
| EBITDA (TTM) | -$44.13M |
| Year Range | $0.63 - $4.69 |
| Target Price | $16.00 |
| Short % | 0.30% |
| Short Ratio | 2.36 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in ASLAN Pharmaceuticals Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
ASLAN Pharmaceuticals Limited had a return of -65.00% year-to-date (YTD) and -77.39% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -65.00% | 19.67% |
| 1 month | -41.67% | 8.42% |
| 6 months | -85.00% | 7.29% |
| 1 year | -77.39% | 12.71% |
| 5 years (annualized) | -52.33% | 10.75% |
| 10 years (annualized) | N/A | 9.87% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -3.61% | -8.75% | -35.34% | -9.96% | -11.53% | -40.43% | -38.39% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for ASLAN Pharmaceuticals Limited (ASLN) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ASLN ASLAN Pharmaceuticals Limited | -0.86 | ||||
^GSPC S&P 500 | 0.91 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ASLAN Pharmaceuticals Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ASLAN Pharmaceuticals Limited was 98.77%, occurring on Dec 1, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.77% | Jun 8, 2018 | 1381 | Dec 1, 2023 | — | — | — |
| -10.31% | May 31, 2018 | 1 | May 31, 2018 | 2 | Jun 4, 2018 | 3 |
| -7.38% | May 14, 2018 | 10 | May 25, 2018 | 1 | May 29, 2018 | 11 |
| -2.32% | May 7, 2018 | 1 | May 7, 2018 | 1 | May 8, 2018 | 2 |
| -0.4% | Jun 6, 2018 | 1 | Jun 6, 2018 | 1 | Jun 7, 2018 | 2 |
Volatility Chart
The current ASLAN Pharmaceuticals Limited volatility is 24.21%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.